This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: discharge medication

Achieving the dose: an audit of discharge medication for the secondary prevention of myocardial infarction

May 2010 Br J Cardiol 2010;17:142-3

Achieving the dose: an audit of discharge medication for the secondary prevention of myocardial infarction

Kyle J Stewart, Pippa Woothipoom, Jonathan N Townend

Abstract

Introduction This retrospective audit was performed to assess whether patients discharged from the cardiology ward at the Queen Elizabeth Hospital, Birmingham, following ST-segment elevation myocardial infarction (STEMI) or non-ST-segment elevation myocardial infarction (NSTEMI) were prescribed the recommended medication at appropriate doses. The evidence for the prognostic benefit of drugs such as angiotensin-converting enzyme (ACE) inhibitors, beta blockers and statins after a myocardial infarction (MI) is derived from studies in which these drugs were used at high doses, such as Acute Infarction Ramipril Efficacy (AIRE),1 Carvedilol Post-I

| Full text
Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now